Literature DB >> 22485193

THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM.

C Belzer1, Q Liu, M C Carroll, L Bry.   

Abstract

The role of complement and complement-fixing IgG isotypes at mucosal surfaces is ill defined. Previous data have demonstrated that survival of an infection with the attaching and effacing pathogen Citrobacter rodentium requires production of systemic and CD4+ T cell-dependent IgG. We have found that both complement and complement-fixing IgG isotypes are needed to survive a C. rodentium infection. Our results indicate that both IgG and complement C3b enter the gut lumen and bind epithelially adherent, and fecally shed C. rodentium. Furthermore, C3-deficient mice demonstrate a profound survival defect, though means to replenish C3 in systemic or mucosal sites restores the protective capacity of complement in the host. Our data provide evidence that both IgG and complement interact constructively on both sides of the epithelium to fight colonizing mucosal infections.

Entities:  

Year:  2011        PMID: 22485193      PMCID: PMC3319158          DOI: 10.1556/EuJMI.1.2011.4.7

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  42 in total

1.  The allogeneic T and B cell response is strongly dependent on complement components C3 and C4.

Authors:  J E Marsh; C K Farmer; S Jurcevic; Y Wang; M C Carroll; S H Sacks
Journal:  Transplantation       Date:  2001-10-15       Impact factor: 4.939

2.  Antibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization.

Authors:  Humberto M Carvalho; Louise D Teel; John F Kokai-Kun; Alison D O'Brien
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

4.  Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus.

Authors:  S Petrella; D Clermont; I Casin; V Jarlier; W Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium.

Authors:  P C D Ferreira; J B da Silva; R M F Piazza; L Eckmann; P L Ho; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

Review 6.  Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.

Authors:  S A Luperchio; D B Schauer
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

7.  The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs.

Authors:  Derry C Roopenian; Gregory J Christianson; Thomas J Sproule; Aaron C Brown; Shreeram Akilesh; Nadja Jung; Stefka Petkova; Lia Avanessian; Eun Young Choi; Daniel J Shaffer; Peter A Eden; Clark L Anderson
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

8.  Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.

Authors:  Cameron P Simmons; Simon Clare; Marjan Ghaem-Maghami; Tania K Uren; Joanna Rankin; Allan Huett; Rob Goldin; David J Lewis; Thomas T MacDonald; Richard A Strugnell; Gad Frankel; Gordon Dougan
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway.

Authors:  Michael J Brady; Kenneth G Campellone; Megha Ghildiyal; John M Leong
Journal:  Cell Microbiol       Date:  2007-05-23       Impact factor: 3.715

10.  Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more
  11 in total

Review 1.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

2.  Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis.

Authors:  Mayara Grizotte-Lake; Guo Zhong; Kellyanne Duncan; Jay Kirkwood; Namrata Iyer; Irina Smolenski; Nina Isoherranen; Shipra Vaishnava
Journal:  Immunity       Date:  2018-12-18       Impact factor: 31.745

3.  Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection.

Authors:  Luis Alonso Diaz; Norman H Altman; Wasif N Khan; Charles N Serhan; Becky Adkins
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

4.  Tpl2 promotes neutrophil trafficking, oxidative burst, and bacterial killing.

Authors:  Nicole V Acuff; Xin Li; Jessica Elmore; Balázs Rada; Wendy T Watford
Journal:  J Leukoc Biol       Date:  2017-03-29       Impact factor: 4.962

5.  In vivo commensal control of Clostridioides difficile virulence.

Authors:  Brintha P Girinathan; Nicholas DiBenedetto; Jay N Worley; Johann Peltier; Mario L Arrieta-Ortiz; Selva Rupa Christinal Immanuel; Richard Lavin; Mary L Delaney; Christopher K Cummins; Maria Hoffman; Yan Luo; Narjol Gonzalez-Escalona; Marc Allard; Andrew B Onderdonk; Georg K Gerber; Abraham L Sonenshein; Nitin S Baliga; Bruno Dupuy; Lynn Bry
Journal:  Cell Host Microbe       Date:  2021-10-11       Impact factor: 21.023

6.  CD40 Ligand Deficient C57BL/6 Mouse Is a Potential Surrogate Model of Human X-Linked Hyper IgM (X-HIGM) Syndrome for Characterizing Immune Responses against Pathogens.

Authors:  Catalina Lopez-Saucedo; Rodolfo Bernal-Reynaga; Jesus Zayas-Jahuey; Silvia Galindo-Gomez; Mineko Shibayama; Carlos Garcia-Galvez; Sergio Estrada-Parra; Teresa Estrada-Garcia
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

Review 7.  Regulation of immune responses by the neonatal fc receptor and its therapeutic implications.

Authors:  Timo Rath; Kristi Baker; Michal Pyzik; Richard S Blumberg
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

8.  Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function.

Authors:  Noora Ottman; Justus Reunanen; Marjolein Meijerink; Taija E Pietilä; Veera Kainulainen; Judith Klievink; Laura Huuskonen; Steven Aalvink; Mikael Skurnik; Sjef Boeren; Reetta Satokari; Annick Mercenier; Airi Palva; Hauke Smidt; Willem M de Vos; Clara Belzer
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

Review 9.  IgG and Fcγ Receptors in Intestinal Immunity and Inflammation.

Authors:  Tomas Castro-Dopico; Menna R Clatworthy
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

10.  A Phase-Variable Surface Layer from the Gut Symbiont Bacteroides thetaiotaomicron.

Authors:  Mao Taketani; Mohamed S Donia; Amy N Jacobson; John D Lambris; Michael A Fischbach
Journal:  MBio       Date:  2015-09-29       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.